|
PDCL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.268300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.592400E-04 |
| Normal-vs-Stage2 |
4.204000E-01 |
| Normal-vs-Stage3 |
4.083800E-01 |
| Normal-vs-Stage4 |
3.059000E-01 |
| Stage1-vs-Stage2 |
1.513410E-01 |
| Stage1-vs-Stage3 |
2.18600000001512E-06 |
| Stage1-vs-Stage4 |
1.175960E-04 |
| Stage2-vs-Stage3 |
1.937640E-01 |
| Stage2-vs-Stage4 |
1.523630E-01 |
| Stage3-vs-Stage4 |
7.344000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.667700E-02 |
| Normal-vs-AfricanAmerican |
2.903200E-01 |
| Normal-vs-Asian |
6.279400E-01 |
| Caucasian-vs-AfricanAmerican |
8.750200E-01 |
| Caucasian-vs-Asian |
9.107600E-01 |
| AfricanAmerican-vs-Asian |
9.674600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.757440E-01 |
| Normal-vs-Female |
3.852100E-02 |
| Male-vs-Female |
3.640800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.657990E-01 |
| Normal-vs-Age(41-60Yrs) |
6.161000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.988800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.119250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.148200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.522830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.151900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.438600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.019400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.158220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.999300E-03 |
| Normal-vs-Grade 2 |
1.752790E-04 |
| Normal-vs-Grade 3 |
6.275800E-01 |
| Normal-vs-Grade 4 |
1.403170E-01 |
| Grade 1-vs-Grade 2 |
2.534500E-02 |
| Grade 1-vs-Grade 3 |
6.157400E-03 |
| Grade 1-vs-Grade 4 |
4.28540000000366E-05 |
| Grade 2-vs-Grade 3 |
4.11709999981191E-07 |
| Grade 2-vs-Grade 4 |
3.54380000000543E-05 |
| Grade 3-vs-Grade 4 |
2.213200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.93035999999092E-05 |
| Normal-vs-ccB subtype |
6.129200E-01 |
| ccA subtype-vs-ccB subtype |
2.2521999998304E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.308600E-01 |
| Normal-vs-N1 |
2.549200E-01 |
| N0-vs-N1 |
2.075200E-01 |
|
|
